Dr. Lisette DePillis is the Norman F. Sprague Jr. Professor of Life Sciences, Professor of Mathematics, and Chair of the Department of Mathematics at Harvey Mudd College. She received her PhD in mathematics from the University of California Los Angeles. Lisette was Director of the Harvey Mudd College Global Clinic Program prior to being elected department chair. Lisette has been recognized for her multidisciplinary research excellence with the Maria Goeppert-Mayer Distinguished Scholar Award from the Argonne National Laboratory. She is also a HERS-CBL Clare Boothe Luce Leadership in STEM Scholar and a Fellow of the American Mathematical Society. In our interview Lisette shared more about her life and work.
Dr. Paul Steinhardt is the Albert Einstein Professor in Science, Professor in the Department of Physics, Professor in the Department of Astrophysical Sciences, and Director of the Princeton Center for Theoretical Sciences at Princeton University. In addition, Paul is author of the popular science book Endless Universe: Beyond the Big Bang and the recently released book The Second Kind of Impossible: The Extraordinary Quest for a New Form of Matter. Paul received his B.S. in physics from the California Institute of Technology (Caltech) and his M.A. and Ph.D. degrees in physics from Harvard University. Afterwards, Paul was a Junior Fellow in the Harvard Society of Fellows. He served on the faculty at the University of Pennsylvania for about 17 years before joining the faculty at Princeton University. Paul has been recognized for his exceptional research as one of the recipients of the 2002 Dirac Medal from the International Centre for theoretical Physics, a recipient of the Oliver E. Buckley Prize of the American Physical Society, a recipient of the John Scott Award, and one of the recipients of the 2018 Aspen Italia Prize. He is a Fellow of the American Physical Society and a Member of the National Academy of Sciences. Paul was also named a Sloan Fellow, a Guggenheim Fellow, the Simons Fellow in Theoretical Physics, a Radcliffe Institute Fellow at Harvard University, a Moore Fellow at Caltech, and a Caltech Distinguished Alumnus. In our interview Paul shared more about his life and science.
Dr. Carla Finkielstein is an Associate Professor of Biological Sciences within the Biocomplexity Institute of Virginia Tech. She is also Director of the Integrated Cellular Response Laboratory at Virginia Tech, a Member of the Executive Committee of the Susan G. Komen Blue Ridge Board, and past member of the Board of Directors of the Virginia Breast Cancer Foundation. Carla received her B.S. and Ph.D. both in Molecular Biology from the University of Buenos Aires in Argentina. Afterwards, she worked as a Research Associate at the Howard Hughes Medical Institute at the University of Colorado Health Sciences Center. Carla then conducted further postdoctoral research at the University of Colorado Health Sciences Center before joining the faculty at Virginia Tech. Carla has been recognized for her research accomplishments with the L. Chely Award for Best PhD Thesis, a Howard Hughes Institute Fellowship for Research, an American Heart Association Postdoctoral Fellowship, the Karin Noss Scholarship for Research Advocacy in Breast Cancer, the Susan G. Komen Award for Junior Investigators, and a National Science Foundation CAREER Award. In our interview Carla shared more about her life and science.
Dr. Todd Zankel is co-founder and Chief Scientific Officer of Mercaptor Discoveries, Inc., a biotech company focused on developing molecules to treat brain injury and degeneration. Todd received his B.A. in Chemistry from Reed College and his Ph.D. in Chemistry from Columbia University. Afterwards, he accepted a position as an NIH postdoctoral fellow at the Plant Gene Expression Center in Berkeley, California as well as the Chemistry Department of ETH in Zurich, Switzerland. Todd then worked for BioMarin Pharmaceutical for about eight years. Before co-founding Mercaptor Discoveries, Todd co-founded Raptor Pharmaceuticals in 2006, acting as Chief Scientific Officer and head of discovery research until 2016 when the company was acquired. In our interview, Todd shared more about his life and science.[Read more…]
Dr. Michael Fox is an Associate Professor of Neurology at the Harvard University Medical School and Director of the Laboratory for Brain Network Imaging and Modulation. In addition, Mike is Associate Director of the Berenson-Allen Center for Noninvasive Brain Stimulation, Co-Director of the Beth Israel Deaconess Medical Center Deep Brain Stimulation Program, Assistant Neuroscientist at Massachusetts General Hospital, and a practicing clinical neurologist at the Beth Israel Deaconess Medical Center. He received his bachelor’s degree in Electrical Engineering from The Ohio State University, and he was awarded his MD and PhD from Washington University in St. Louis. Afterwards, Mike completed a medical internship at Barnes Jewish Hospital in St. Louis. Next, he completed his Neurology Residency and Movement Disorders Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston before becoming a faculty member with the Beth Israel Deaconess Medical Center and Harvard Medical School. Mike is the recipient of the inaugural Trailblazer Prize for Clinician-Scientists from the Foundation for the National Institutes of Health. In our interview, Mike tells us more about his life and science.
Dr. Janine Austin Clayton is the Associate Director for Research on Women’s Health and Director of the Office of Research on Women’s Health at the National Institutes of Health. She was awarded her undergraduate degree with honors from Johns Hopkins University and her medical degree from Howard University College of Medicine. Afterwards, Janine completed a residency in ophthalmology at the Medical College of Virginia and fellowships at the Wilmer Eye Institute at Johns Hopkins Hospital as well as the National Eye Institute (NEI). Janine is a board-certified ophthalmologist. She served as a Clinical Investigator at NEI for a number of years, and prior to her current appointments, she was the Deputy Clinical Director of NEI. Janine has received numerous awards and honors for her exceptional work, including the Senior Achievement Award from the Board of Trustees of the American Academy of Ophthalmology, selection as a Silver Fellow by the Association for Research in Vision and Ophthalmology, the European Uveitis Patient Interest Association Clinical Uveitis Research Award, the American Medical Women’s Association Lila A. Wallis Women’s Health Award, the Wenger Award for Excellence in Public Service, and the Bernadine Healy Award for Visionary Leadership in Women’s Health. In addition, Janine was selected as an honoree for the Woman’s Day Red Dress Awards and the American Medical Association’s Dr. Nathan Davis Awards for Outstanding Government Service. In our interview, Janine speaks more about her experiences in life and science.
Dr. Joseph S. Takahashi is Professor and Chair of Neuroscience and the Loyd B. Sands Distinguished Chair in Neuroscience at the University of Texas Southwestern Medical Center. He is also an Investigator in the Howard Hughes Medical Institute. Joe received his B.A. in biology from Swarthmore College and he was awarded his Ph.D. in neuroscience from the University of Oregon in Eugene. Afterwards, he conducted postdoctoral research as a pharmacology research associate at the National Institute of Mental Health. Before moving to UT Southwestern, Joe served on the faculty of Northwestern University for 26 years. Over the course of his career, Joe has received numerous awards and honors including the Honma Prize in Biological Rhythms Research, the NSF Presidential Young Investigator Award, the Searle Scholars Award, the Bristol-Myers Squibb Unrestricted Grant in Neuroscience, the C. U. Ariens Kappers Medal, the Outstanding Scientific Achievement Award from the Sleep Research Society, the W. Alden Spencer Award in Neuroscience from Columbia University, and the Peter C. Farrell Prize in Sleep Medicine from the Harvard Medical School Division of Sleep Medicine. He has also been elected as a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Association for the Advancement of Science, a Member of the National Academy of Sciences, a Member of the National Academy of Medicine, and an Honorary Member of The Japanese Biochemical Society. In our interview, Joe shared his experiences in life and science.
Dr. Barbara Katzenback is an Assistant Professor in the Department of Biology at the University of Waterloo. Barb earned her BSc with Honors in Immunology and Infection from the University of Alberta. She received her PhD in Physiology, Cell, and Developmental Biology from the University of Alberta as well. Barb was next awarded a Natural Sciences and Engineering Research Council (NSERC) Postdoctoral Fellowship to conduct research at Carleton University, followed by an NSERC Banting Postdoctoral Fellowship to conduct research at the University of Waterloo before joining the faculty there. In our interview, Barb speaks more about her experiences in life and science.
Dr. Robert A. Beardsley or “Al” is a Co-Founder and the Chief Operating Officer at Galera Therapeutics, a clinical-stage biotech company discovering and developing innovative cancer treatments. Al received his BS in Chemical Engineering from the University of Iowa, an MBA in finance from the University of Chicago, and subsequently his PhD in Biochemical Engineering from the University of Iowa. Prior to co-founding Galera Therapeutics, Al served as CEO at Metabolic Solutions Development Corporation, CEO of Kereos, acting CEO at Metaphore Pharmaceuticals, and he has held various roles at Confluence Life Sciences, SImile Investors, bioStrategies Group, and Vector Securities International. Galera Therapeutics’ new drug Abasopasem Manganese has been designated as a “Breakthrough Therapy” by the FDA for reduction in the duration, incidence, and severity of oral mucositis induced by radiation therapy in cancer patients. Recently, Al and the team at Galera Therapeutics raised $150 million in investment for their company, which represents the largest single capital round ever raised by a life-sciences company founded in St. Louis. In this podcast interview, Al spoke with us about his experiences in life and science.
Dr. Chad Orzel is the R. Gordon Gould Associate Professor of Physics at Union College. He is also author of the popular science books How to Teach Physics to Your Dog, How to Teach Relativity to Your Dog, Eureka: Discovering Your Inner Scientist, and the soon-to-be-released book Breakfast with Einstein: The Exotic Physics of Everyday Objects. In addition, Chad regularly contributes blog articles for Forbes Magazine. He received his B.A. in Physics from Williams College and his Ph.D. in Chemical Physics from the University of Maryland. Before joining the faculty at Union College, Chad conducted postdoctoral research in the Physics Department at Yale University. In our interview, Chad shared his experiences from his life and science.